Cargando…
Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study
BACKGROUND: Neurocognitive impairment is associated with psychological morbidities, such as depression and anxiety, among people living with HIV. The presence of these comorbidities affects viral load suppression, treatment adherence, quality of life, treatment outcomes, and functionality. Despite t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087279/ https://www.ncbi.nlm.nih.gov/pubmed/35558427 http://dx.doi.org/10.3389/fpsyt.2022.732229 |
_version_ | 1784704169761832960 |
---|---|
author | Tareke, Minale Belete, Tilahun Ergetie, Temesgen Tadesse, Meseret Menberu, Melak Ketemaw, Asmamaw |
author_facet | Tareke, Minale Belete, Tilahun Ergetie, Temesgen Tadesse, Meseret Menberu, Melak Ketemaw, Asmamaw |
author_sort | Tareke, Minale |
collection | PubMed |
description | BACKGROUND: Neurocognitive impairment is associated with psychological morbidities, such as depression and anxiety, among people living with HIV. The presence of these comorbidities affects viral load suppression, treatment adherence, quality of life, treatment outcomes, and functionality. Despite this fact, there is a dearth of studies that examined the triple burden of neurocognitive impairment and co-occurring depression and anxiety among antiretroviral therapy attendees in Ethiopia. This study aimed to assess the magnitude of HIV-associated neurocognitive impairment and co-occurring depression and anxiety at the same time among people living with HIV/AIDS. METHOD: We conducted an institution-based multicenter cross-sectional study in Bahir Dar, Northwest Ethiopia. A total of 410 study participants were selected using a systematic random sampling technique. Neurocognitive impairment was assessed using the International HIV Dementia Scale. Co-occurring depression and anxiety were assessed using the Hospital Anxiety and Depression Scale. A semi-structured questionnaire was applied to collect data on sociodemographic and clinical-related characteristics. Data were analyzed using descriptive statistics and univariate and multivariable logistic regression. RESULTS: Two-thirds (66.8%) of the people living with HIV had neurocognitive impairment. The prevalence of co-occurring depression and anxiety was found in 39.8%. Women with HIV, people with comorbid chronic medical illness, and those under a second-line treatment regimen were factors associated with neurocognitive impairment. Furthermore, pill burden, second-line treatment regimen, HIV clinical stages, social support, HIV-perceived stigma, and neurocognitive impairment were associated factors with co-occurring depression and anxiety. CONCLUSIONS: We found a high prevalence of neurocognitive impairment and co-occurring depression and anxiety among people living with HIV/AIDs. Further research is needed to assess the clinical course of neurocognitive impairment and co-occurring depression and anxiety. |
format | Online Article Text |
id | pubmed-9087279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90872792022-05-11 Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study Tareke, Minale Belete, Tilahun Ergetie, Temesgen Tadesse, Meseret Menberu, Melak Ketemaw, Asmamaw Front Psychiatry Psychiatry BACKGROUND: Neurocognitive impairment is associated with psychological morbidities, such as depression and anxiety, among people living with HIV. The presence of these comorbidities affects viral load suppression, treatment adherence, quality of life, treatment outcomes, and functionality. Despite this fact, there is a dearth of studies that examined the triple burden of neurocognitive impairment and co-occurring depression and anxiety among antiretroviral therapy attendees in Ethiopia. This study aimed to assess the magnitude of HIV-associated neurocognitive impairment and co-occurring depression and anxiety at the same time among people living with HIV/AIDS. METHOD: We conducted an institution-based multicenter cross-sectional study in Bahir Dar, Northwest Ethiopia. A total of 410 study participants were selected using a systematic random sampling technique. Neurocognitive impairment was assessed using the International HIV Dementia Scale. Co-occurring depression and anxiety were assessed using the Hospital Anxiety and Depression Scale. A semi-structured questionnaire was applied to collect data on sociodemographic and clinical-related characteristics. Data were analyzed using descriptive statistics and univariate and multivariable logistic regression. RESULTS: Two-thirds (66.8%) of the people living with HIV had neurocognitive impairment. The prevalence of co-occurring depression and anxiety was found in 39.8%. Women with HIV, people with comorbid chronic medical illness, and those under a second-line treatment regimen were factors associated with neurocognitive impairment. Furthermore, pill burden, second-line treatment regimen, HIV clinical stages, social support, HIV-perceived stigma, and neurocognitive impairment were associated factors with co-occurring depression and anxiety. CONCLUSIONS: We found a high prevalence of neurocognitive impairment and co-occurring depression and anxiety among people living with HIV/AIDs. Further research is needed to assess the clinical course of neurocognitive impairment and co-occurring depression and anxiety. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9087279/ /pubmed/35558427 http://dx.doi.org/10.3389/fpsyt.2022.732229 Text en Copyright © 2022 Tareke, Belete, Ergetie, Tadesse, Menberu and Ketemaw. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Tareke, Minale Belete, Tilahun Ergetie, Temesgen Tadesse, Meseret Menberu, Melak Ketemaw, Asmamaw Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study |
title | Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study |
title_full | Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study |
title_fullStr | Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study |
title_full_unstemmed | Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study |
title_short | Triple Burden of Neurocognitive Impairment and Co-occurring Depression and Anxiety Among People Living With HIV in Bahir Dar, Ethiopia: A Multicenter Study |
title_sort | triple burden of neurocognitive impairment and co-occurring depression and anxiety among people living with hiv in bahir dar, ethiopia: a multicenter study |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087279/ https://www.ncbi.nlm.nih.gov/pubmed/35558427 http://dx.doi.org/10.3389/fpsyt.2022.732229 |
work_keys_str_mv | AT tarekeminale tripleburdenofneurocognitiveimpairmentandcooccurringdepressionandanxietyamongpeoplelivingwithhivinbahirdarethiopiaamulticenterstudy AT beletetilahun tripleburdenofneurocognitiveimpairmentandcooccurringdepressionandanxietyamongpeoplelivingwithhivinbahirdarethiopiaamulticenterstudy AT ergetietemesgen tripleburdenofneurocognitiveimpairmentandcooccurringdepressionandanxietyamongpeoplelivingwithhivinbahirdarethiopiaamulticenterstudy AT tadessemeseret tripleburdenofneurocognitiveimpairmentandcooccurringdepressionandanxietyamongpeoplelivingwithhivinbahirdarethiopiaamulticenterstudy AT menberumelak tripleburdenofneurocognitiveimpairmentandcooccurringdepressionandanxietyamongpeoplelivingwithhivinbahirdarethiopiaamulticenterstudy AT ketemawasmamaw tripleburdenofneurocognitiveimpairmentandcooccurringdepressionandanxietyamongpeoplelivingwithhivinbahirdarethiopiaamulticenterstudy |